Skip to contentC
Core Scientific, Inc./tx
C
CORZZCore Scientific, Inc./tx Q1 2025 · 10-Q
Revenue$79.53M$79.53M−55.6% vs Q1 2024 Net Income$576.25M$576.25M+173.5% vs Q1 2024 EPS Diluted$1.24$1.24+59.0% vs Q1 2024 Gross Profit$8,213,000−89.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Core Scientific, Inc./tx · CIK 1839341 · Engraved from SEC EDGAR
Operating Cash Flow-$45,041,000N/M Free Cash Flowderived-$129,021,000N/M Margins · derivedGross margin10.3%−33.0 pt vs Q1 2024
Operating margin-59.1%−90.0 pt vs Q1 2024
Net margin724.6%+607.1 pt vs Q1 2024
ended Mar 31, 2025 · filed May 7, 2025 · 37 d after period end